In response to the growing interest in glucagon-like peptide-1 (GLP-1) weight-loss medications and the cost challenges employers face to offer coverage, Liviniti, a national leader in PBM innovation, ...
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...
A target trial emulation study compared risk for depression among older adults with type 2 diabetes initiating treatment with ...
Drugs approved for diabetes and obesity might be useful for the treatment of cognitive and mental health disorders, according ...
A groundbreaking national poll conducted on behalf of the Diabetes Patient Advocacy Coalition (DPAC) reveals overwhelming bipartisan support for Medicare and Medicaid coverage of glucagon-like peptide ...
The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...
Here are some practical guidelines and considerations for safely exercising while on GLP-1 medications. Text Callout : Key Takeaways - Exercising on GLP-1s How GLP-1 Medications Affect the Body ...
5h
Tribune Content Agency on MSNHow GLP-1 drugs could revolutionize retirementYou know something is a big deal when Big Food gets nervous. The culprit? Popular weight-loss drugs like Ozempic, which mimic the hormone glucagon-like peptide-1 (GLP-1) to curb hunger. But these ...
Ozempic, Wegovy, Mounjaro, and Saxenda – from Hollywood to high street pharmacies, they are everywhere. These are the weight loss drugs that have been hailed as a “ miracle ” and the “ wonder drug [s] ...
When her consultant offered 20st Sarah a brand new injection called Ozempic that promised to treat her diabetes and help her ...
“Queer Eye” star Jonathan Van Ness recently posted before-and-after photos to show off his drastic weight loss. Van Ness, 37, took to his Instagram Story Sunday to share a shirtless image of himself ...
Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results